Literature DB >> 10202969

Quantitative analysis of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol in human plasma using high-performance liquid chromatography.

T L Taras1, G T Wurz, U Hellmann-Blumberg, M W DeGregorio.   

Abstract

A highly sensitive and precise high-performance liquid chromatography (HPLC) assay was developed and validated for the quantitation of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl) phenoxy]ethanol (FC-1271a) in human plasma. Plasma samples (1.0 ml) containing FC-1271a and internal standard (toremifene citrate; Farestono) were extracted using a 2% 1-butanol, 98% hexane solution with an extraction efficiency of >97%. Samples were reconstituted in methanol, irradiated with high intensity ultraviolet light (254 nm) for 1 min, and injected onto a C18 reverse phase column. Samples were eluted isocratically at a flow-rate of 0.5 ml/min with a mobile phase consisting of 6.5% water and 0.5% triethylamine in methanol. The fluorescence of photochemically activated compounds was detected using a fluorometer set at an excitation wavelength of 266 nm and emission wavelength of 370 nm. Under these assay conditions, standard calibration curves were linear through a concentration range of 10-400 ng/ml. In summary, we have developed and validated an HPLC assay to quantitate FC-1271a in human plasma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202969     DOI: 10.1016/s0378-4347(98)00571-4

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  2 in total

1.  Effects of chemical enhancers on human epidermal membrane: Structure-enhancement relationship based on maximum enhancement (E(max)).

Authors:  Sarah A Ibrahim; S Kevin Li
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

2.  Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.

Authors:  Ruria Namba; Lawrence J T Young; Jeannie E Maglione; Erik T McGoldrick; Stephenie Liu; Gregory T Wurz; Michael W DeGregorio; Alexander D Borowsky; Carol L MacLeod; Robert D Cardiff; Jeffrey P Gregg
Journal:  Breast Cancer Res       Date:  2005-09-13       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.